Federal award
PSIOXUS THERAPEUTICS LIMITED
HDTRA112C0084
Contract
Obligated and Ceiling
- Obligated (net)
- $1,980,749.00
- Ceiling (potential value, not spending)
- $3,945,353.00
- Current value
- $1,980,749.00
- Gross positive obligations
- $2,014,916.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- PSIOXUS THERAPEUTICS LIMITED · N7M1TQCKJRM1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- PSIOXUS THERAPEUTICS LIMITED · N7M1TQCKJRM1
- Awarding agency
- Department of War · sub-agency 9763 · office S5102A
- Funding agency
- Department of War · sub-agency 9761
- Product or service (PSC)
- AD92 · R&D- DEFENSE OTHER: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- HDTRA112C0084
- Award type code
- D
- Actions
- 11 · Sep 4, 2012 to Oct 1, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History11
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Oct 1, 2021 | FY2022 | A00002 | K | $0.00 | — |
| Mar 31, 2020 | FY2020 | A00001 | C | −$34,167.00 | — |
| Dec 9, 2019 | FY2020 | ARZ998 | W | $0.00 | — |
| Aug 27, 2014 | FY2014 | P00007 | C | $296,264.00 | — |
| Jul 14, 2014 | FY2014 | P00006 | C | $255,645.00 | — |
| May 28, 2014 | FY2014 | P00005 | M | $0.00 | — |
| Mar 18, 2014 | FY2014 | P00004 | C | $553,113.00 | — |
| Aug 20, 2013 | FY2013 | P00003 | G | $79,583.00 | — |
| Jul 2, 2013 | FY2013 | P00002 | M | $122,263.00 | — |
| Nov 20, 2012 | FY2013 | P00001 | C | $143,498.00 | — |
| Sep 4, 2012 | FY2012 | 0 | — | $564,550.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.